BCC Research Blog | Industry Analysis and Business Consulting

Top 10 Mobile Apps Companies for DNA Sequencing

Written by BCC Research Staff Analysts | Nov 17, 2026, 1:16:23 PM

DNA sequencing has moved from million-dollar research programs to pocket-sized devices paired with smartphones. Mobile apps now let clinicians, researchers, field scientists, and individuals interpret genetic data in real time, whether they are tracking an outbreak in a remote region, assessing hereditary cancer risk, or tracing ancestry from a living room. As hardware shrinks and costs fall, the software layer that makes genomic data usable on mobile devices has become a market in its own right.

According to BCC Research, the global market for mobile apps for DNA sequencing was valued at $777.1 million in 2025 and is projected to reach $2,430.9 million by 2031, a CAGR of 21.1% from 2026 to 2031. Four forces underpin that trajectory:

• Declining sequencing costs: a full human genome now costs roughly $600, compared with millions in the early 2000s.

• The spread of portable nanopore devices.

• Expanding cloud and AI infrastructure.

• Surging consumer interest in ancestry and personal health genomics.

Identifying the companies driving this growth means looking across the value chain: instrument makers building mobile interfaces into their platforms, cloud genomics providers enabling mobile access to complex analysis pipelines, and consumer genealogy companies deploying whole-genome sequencing at scale. The ten companies profiled below reflect the breadth of that landscape.

Market Context: Segments and Regional Leadership

By Technology

• Next-generation sequencing (NGS): $524.4 million in 2025 (67.5% of the market), growing at a 21.2% CAGR. High-throughput, increasingly affordable whole-genome and whole-exome datasets create the greatest demand for mobile interpretation tools.

• Third-generation sequencing: $156.4 million, growing at 21.0%. Long-read portable platforms such as Oxford Nanopore's MinION pair naturally with mobile apps for field analysis.

• Sanger sequencing: $59.9 million, growing at 20.8%, supported by clinical confirmatory testing and educational applications.

By End Use

Genealogy is the largest consumer segment at $308.2 million in 2025, growing at 20.6%. Computational biology and rare disease applications are another substantial driver, particularly in North America.

By Region

• North America: The largest share, at 46.1%, supported by a dense genomics research ecosystem, high smartphone penetration, and strong consumer engagement with direct-to-consumer genetic testing.

• Europe: Together with North America, holds a combined 67.9% share, backed by national genomics programs and digital health infrastructure.

• Asia-Pacific: The fastest-growing region, with the highest CAGR of 21.7%, driven by large-scale sequencing initiatives in China, India, Japan, and South Korea and growing public health investment in Southeast Asia.

• Rest of the World: Lags at an 18.7% CAGR, with South America at $48.8 million and Middle East and Africa at $38.3 million in 2025, both gradually building presence.

The Top 10 Companies in the Mobile Apps for DNA Sequencing Market

1. Illumina Inc.

• Headquarters: San Diego, California, U.S.

• Founded: 1998

• Revenue: $4.34 billion (FY2025)

• Employees: 8,600

• Focus: Sequencing, Microarrays

Illumina occupies the dominant position in DNA sequencing infrastructure worldwide. Its BaseSpace Sequence Hub provides cloud-based NGS data management and analysis accessible via mobile interfaces, while its DRAGEN secondary analysis platform handles compute-intensive genomic tasks at speed. In 2026, the company acquired short-read sequencing assets from PacBio for $48 million and is collaborating with Tempus AI to accelerate clinical NGS adoption through AI-powered multimodal data integration. Startup accelerators and partnership programs extend its reach into mobile tool development.

2. Oxford Nanopore Technologies plc.

• Headquarters: Oxford, U.K.

• Founded: 2005

• Revenue: $234.1 million (FY2025)

• Employees: 1,316

• Focus: Nanopore-based DNA and RNA sequencing, Research, Industrial, Clinical, and Biopharma sequencing applications

Oxford Nanopore is the company most directly enabling field-based mobile genomics. Its MinION handheld sequencer generates long-read data suited for real-time analysis via apps including MinKNOW and Genopo, bringing sequencing into hospitals, field laboratories, and outbreak response settings. The company invested $126.4 million in R&D in 2024 and operates across more than 125 countries through 63 distributors and 489 commercial teams. Its portable platforms sit at the heart of the third-generation sequencing segment's growth.

3. QIAGEN

• Headquarters: Venlo, The Netherlands

• Founded: 1984

• Revenue: $2,090.0 million (FY2025)

• Employees: 5,700

• Focus: Sample Technologies, Diagnostic Solutions, PCR/Nucleic Acid Amplification, NGS, Molecular Diagnostics, Life Sciences Solutions, QIAGEN Digital Insights

QIAGEN serves more than 500,000 customers across life sciences and molecular diagnostics through a distribution network spanning over 60 countries. Its QIAGEN Digital Insights (QDI) division, which grew at a double-digit constant exchange rate in Q4 2025, provides bioinformatics platforms increasingly accessible through mobile and web interfaces. The company's integrated approach — combining sample preparation, diagnostics, and digital analysis — positions it strongly across both clinical and research segments of the mobile genomics market.

4. Thermo Fisher Scientific Inc.

• Headquarters: Waltham, Massachusetts, U.S.

• Founded: 1956

• Revenue: $44,556 million (FY2025)

• Employees: 125,000

• Focus: Life Science Solutions, DNA Sequencing (Sanger and NGS), Genetic Analysis Instruments, Gene Synthesis, Capillary Electrophoresis-Based Sequencing Solutions

Thermo Fisher holds the second-ranked global position in the mobile apps for DNA sequencing market in 2025. Its Applied Biosystems 3500 and 3730 Genetic Analyzers anchor its Sanger sequencing portfolio, while its NGS offerings extend into higher-throughput applications. Mobile and software tools including the Microsatellite Analysis App, GeneArt Strings Assistant, and a dedicated Sanger sequencing educational app reflect the company's effort to build mobile touchpoints across research, clinical, and educational contexts.

5. M42

• Headquarters: Abu Dhabi, UAE

• Founded: 2023

• Employees: 20,000

• Focus: Sequencing, Integrated Health Solutions, Population Health Initiatives, Precision Medicine, Preventive Care

M42 is a fast-growing health technology company pursuing population-scale genomics with a direct focus on mobile accessibility. Its Emirati Genome Program (EGP) decodes the genetic makeup of the UAE population to enable personalized and preventive healthcare, with mobile platforms serving as the interface between participants and their genomic data. The Abu Dhabi BioBank complements this by advancing drug discovery and regional biobanking standards. M42's integrated model — combining sequencing with precision and preventive care — positions it as a key player in the Middle East's emerging genomics market.

6. 23andMe Research Institute

• Headquarters: South San Francisco, California, U.S.

• Founded: 2006

• Focus: Direct-to-consumer genetic testing, Biomedical and genetic research, Ancestry services, Health insights and predisposition reporting

23andMe Research Institute emerged from the restructuring of 23andMe Holding Co. following its bankruptcy, acquiring the core personal genomics and research services to continue large-scale crowdsourced genetic research. The organization maintains ethical data stewardship through structures including a privacy advisory board, and its research model connects millions of consumer genetic profiles with scientific inquiry into disease and health outcomes. Its mobile and consumer-facing platforms remain one of the most recognized entry points for individuals engaging with their own genomic data.

7. DNAnexus Inc.

• Headquarters: Mountain View, California, U.S.

• Founded: 2009

• Focus: Cloud-based genomic data management, Multi-omic analysis, DNA sequencing analysis, Cloud computing for genomics, API integration for mobile and web sequencing applications

DNAnexus provides the cloud infrastructure that enables many mobile genomic workflows to function at scale. Its platform runs compute-intensive tasks — basecalling, alignment, variant calling, long-term storage — on cloud resources via AWS and Microsoft Azure, delivering results to mobile and web interfaces. In 2024, it collaborated with Element Biosciences to combine AVITI sequencing performance with its multi-omic analysis platform. Its APIs support direct integration with mobile apps, enabling real-time upload, visualization, and sharing of sequence data.

8. Helix Inc.

• Headquarters: San Mateo, California, U.S.

• Founded: 2015

• Focus: Sequencing, Population genomics, Backend infrastructure for mobile genomics apps, Hereditary cancer testing

Helix operates as a backend enabler for mobile genomics, providing sequencing infrastructure and population genomics capabilities that partner companies build upon to deliver consumer and clinical apps. Backed by over $300 million in funding from investors including Warburg Pincus, Kleiner Perkins, and Mayo Clinic, the company partnered with Veracyte in 2025 to expand access to hereditary cancer genomic insights alongside the Decipher Prostate test. A 2026 partnership with Mawi DNA Technologies expands non-invasive sample collection capabilities, broadening its reach into new patient populations.

9. MyHeritage Ltd.

• Headquarters: Or Yehuda, Israel

• Founded: 2003

• Focus: Genealogy and family history platform, DNA testing and sequencing, DNA matching and ethnicity estimation, AI-powered photo tools, Mobile apps for genealogy and DNA insights

MyHeritage made a significant strategic move in October 2025 by becoming the first major consumer DNA testing company to upgrade its DNA test to whole-genome sequencing at scale, improving accuracy in DNA matching and ethnicity results and creating a platform for new mobile genealogy products. The company also acquired MesAieux.com to strengthen its position in the Francophone genealogy market. With mobile apps spanning family tree building, historical record search, AI photo tools, and DNA result interaction across 50 languages, it is firmly positioned in the genealogy segment.

10. Nebula Genomics

• Headquarters: Garden City, New York, U.S.

• Founded: 2018

• Focus: Whole-genome sequencing (direct-to-consumer), Personal genomics and DNA insights, Privacy-preserving genomic data platforms, Mobile platforms for genomic data control and access

Founded by Harvard Medical School geneticist George Church alongside Dennis Grishin and Kamal Obbad, Nebula Genomics built its model around making whole-genome sequencing affordable while giving users meaningful control over their genetic data. Its blockchain-inspired framework enables secure data sharing for research without ceding ownership, and its mobile platforms allow users to manage permissions and access DNA insights directly. The company raised $4.3 million in seed funding from investors including Khosla Ventures, Arch Venture Partners, and Fenbushi Capital, and continues expanding mobile access to ancestry and health-related genomic reporting.

Conclusion

The mobile apps for DNA sequencing market is maturing rapidly on several fronts at once. Sequencing hardware is portable and affordable enough for field deployment, cloud and AI infrastructure can deliver complex genomic analysis to a smartphone screen, and consumer appetite for genetic insight, whether for ancestry, health risk, or clinical care, continues to grow. The companies profiled here reflect the diversity of the opportunity: instrument makers extending into software, cloud platforms enabling mobile access, and consumer brands moving toward whole-genome sequencing as a standard offering.

With the market projected to exceed $2.4 billion by 2031 at a 21.1% CAGR, competition will intensify around three areas:

• Data privacy compliance

• Processing capability at the edge

• Interoperability with evolving sequencing hardware

Companies that connect high-quality sequencing infrastructure to intuitive, secure, and clinically credible mobile experiences are best placed to capture disproportionate share. North America's continued dominance and Asia-Pacific's 21.7% CAGR suggest that geographic expansion and population-scale genomics programs will be among the most important growth vectors over the forecast period.

Learn More and Take Action:

Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.

Contact us today to find out more.